The a2 Milk Company Limited logo

Ongoing Disclosure Notice

Insider Disclosure6 April 2017ATMConsumer Staples

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and

Name of listed issuer:

The a2 Milk Company Limited

Date this disclosure made:

06/04/2017

Date of last disclosure:

29/03/2017

Director or senior manager giving disclosure

Full name(s):

John Scott WOTHERSPOON

Name of listed issuer:

The a2 Milk Company Limited (Company)

Name of related body corporate (if applicable):

Position held in listed issuer:Chief Executive, UK and China

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products: Ordinary Shares

Nature of the affected relevant interest(s):

(1) Legal Ownership and Beneficial Interest in

unlisted options to subscribe for Ordinary

Shares (Options); (2) By acting in concert with

his spouse Susannah Clare Day, Mr

Wotherspoon has the power to exercise rights

to vote attached to, and to dispose of, the

Ordinary Shares held by Susannah Clare Day;

(3) Legal Ownership and Beneficial Interest in

Ordinary Shares

For that relevant interest-


Number held in class before acquisition or disposal:3,931,250 Options

Number held in class after acquisition or disposal:

(1) 3,631,998 Options (2) 150,000 Ordinary

Shares; (3) 74,252 Ordinary Shares

Current registered holder(s):

John Scott WOTHERSPOON

Registered holder(s) once transfers are registered:

(1) John Scott WOTHERSPOON; (2)

Susannah Clare DAY; (3) John Scott

WOTHERSPOON

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)

Type of affected derivative:

Class of underlying financial products:

Details of affected derivative-

The notional value of the derivative (if any) or the notional amount of underlying financial products

(if any):

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative(if any):

The price specified in the terms of the derivative (if any):

Any other details needed to understand how the amount of the consideration payable under the

derivative or the value of the derivative is affected by the value of the underlying financial

products:

For that derivative,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the relevant interest

in the derivative:

Details of transactions giving rise to acquisition or disposal

Total number of transactions to which notice relates: Three

Details of transactions requiring disclosure-

Date of transaction:

(1) and (2) 04/04/2017; (2) 05/04/2017

Nature of transaction:
(1) Exercise of Options; (2) Transfer of

Ordinary Shares to spouse, Susannah Clare

Day; (3) On-market sale of Ordinary Shares

Name of any other party or parties to the transaction (if known):

(1) N/A; (2) Susannah Clare Day; (3) Unknown

The consideration, expressed in New Zealand dollars, paid or recieved for the acquisition or

disposal. If the consideration was not in cash and cannot be readily by converted into a cash

value, describe the consideration:

(1) $188,528.76; (2) Nil; (3) $225,221.85

Number of financial products to which the transaction related:

(1) 299,252 Options; (2) 150,000 Ordinary

Shares; (3) 75,000 Ordinary Shares

If the issuer has a financial products trading policy that prohibits directors or senior managers

from trading during any period without written clearance (a closed period) include the following

details—

Whether relevant interests were aquired or disposed of during a closed period:No

Whether prior written clearance was provided to allow the aquisition or disposal to proceed during

the closed period:

No

Date of the prior written clearance (if any):N/A

Summary of other relevant interests after acquisition or disposal:

Class of quoted financial products:

Nature of relevant interest:

For that relevant interest,-

Number held in class:

Current registered holder(s):

For a derivative relevant interest,-

Type of derivative:

Details of derivative,-

The notional value of the derivative (if any) or the notional amount of underlying financial products

(if any):

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative (if any):

The price's specified terms (if any):

Any other details needed to understand how the amount of the consideration payable under the

derivative or the value of the derivative is affected by the value of the underlying financial

products:

For that derivative relevant interest,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the relevant interest

in the derivative:

Cerification

I certify that, to the best of my knowledge and belief, the information contained in this disclosure is

correct and that I am duly authorised to make this disclosure by all persons for whom it is made.

Signature of director or officer:

Date of signature:

or

Signature of person authorised to sign on behalf of director or officer:

Date of signature:

Name and title of authorised person:

Notes

Use this form to disclose all the aquisitions and disposals by a director or senior manager of a

listed issuer, or of a related body corporate, or in specified derivatives. The disclosure must be

made within—

(a) 20 working days after the first aquisition or disposal disclosed in this notice if the

aquisitions or disposals are of a kind referred to in section 297(2)(a) of the Financial Markets

Conduct Act 2013; or

(b) in any other case, 5 trading days after the first aquisition or disposal disclosed in

this notice.

6th April 2017

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.

  • SML — Synlait Milk Limited: Ongoing disclosure notice
    2017-04-05

    Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Synlait Milk Limited Date this disclosure made: 5-Apr-17 Date of last disclosure:…”

  • SUM — Summerset Group Holdings Limited: Ongoing Disclosure Notice (Anne Urlwin)
    2017-03-09

    Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Summerset Group Holdings Limited Date this disclosure made: 10 March 2017 Date of…”

  • AFT — AFT Pharmaceuticals Limited: Director and senior manager disclosure notice
    2017-01-20

    Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: AFT Pharmaceuticals Limited Date this disclosure made: 20-Jan-17 Date of last disc…”